Wu Y, Hu S, Yan X, Peng F, Tan J, Guo T
J Cardiovasc Dev Dis. 2022; 9(9).
PMID: 36135453
PMC: 9506206.
DOI: 10.3390/jcdd9090308.
Hu S, Tan J, Liu S, Guo T, Song W, Peng F
J Thromb Thrombolysis. 2021; 53(4):926-933.
PMID: 34705198
DOI: 10.1007/s11239-021-02594-1.
Inampudi C, Tedford R, Hemnes A, Hansmann G, Bogaard H, Koestenberger M
Cardiovasc Diagn Ther. 2020; 10(5):1659-1674.
PMID: 33224779
PMC: 7666956.
DOI: 10.21037/cdt-20-348.
Kiely D, Levin D, Hassoun P, Ivy D, Jone P, Bwika J
Pulm Circ. 2019; :2045894019841990.
PMID: 30880632
PMC: 6732869.
DOI: 10.1177/2045894019841990.
Bryce Y, Santos E
Clin Imaging. 2018; 50:185-187.
PMID: 29649782
PMC: 8985418.
DOI: 10.1016/j.clinimag.2018.04.004.
2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.
Hsu C, Ho W, Huang W, Chiu Y, Hsu T, Kuo P
Acta Cardiol Sin. 2016; 30(5):401-44.
PMID: 27122817
PMC: 4824720.
Pulmonary hypertension: diagnostic and therapeutic challenges.
Bazan I, Fares W
Ther Clin Risk Manag. 2015; 11:1221-33.
PMID: 26316767
PMC: 4544628.
DOI: 10.2147/TCRM.S74881.
Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course.
Baldi F, Fuso L, Arrighi E, Valente S
Ther Clin Risk Manag. 2014; 10:825-39.
PMID: 25328398
PMC: 4199557.
DOI: 10.2147/TCRM.S48920.
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Chronic thromboembolic pulmonary hypertension.
Mayer E, Idrees M
Ann Thorac Med. 2014; 9(Suppl 1):S62-6.
PMID: 25076999
PMC: 4114273.
DOI: 10.4103/1817-1737.134037.
Current clinical management of pulmonary arterial hypertension.
Zamanian R, Kudelko K, Sung Y, De Jesus Perez V, Liu J, Spiekerkoetter E
Circ Res. 2014; 115(1):131-147.
PMID: 24951763
PMC: 4452016.
DOI: 10.1161/CIRCRESAHA.115.303827.
Impact of differential right-to-left shunting on systemic perfusion in pulmonary arterial hypertension.
Weimar T, Watanabe Y, Kazui T, Lee U, Montecalvo A, Schuessler R
Catheter Cardiovasc Interv. 2012; 81(5):888-95.
PMID: 22511538
PMC: 3410055.
DOI: 10.1002/ccd.24458.
Treatment of pulmonary hypertension.
Patel R, Aronow W, Patel L, Gandhi K, Desai H, Kaul D
Med Sci Monit. 2012; 18(4):RA31-9.
PMID: 22460104
PMC: 3560813.
DOI: 10.12659/msm.882607.
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Kearon C, Akl E, Comerota A, Prandoni P, Bounameaux H, Goldhaber S
Chest. 2012; 141(2 Suppl):e419S-e496S.
PMID: 22315268
PMC: 3278049.
DOI: 10.1378/chest.11-2301.
Therapeutic strategies in pulmonary hypertension.
Fuso L, Baldi F, Di Perna A
Front Pharmacol. 2011; 2:21.
PMID: 21687513
PMC: 3108478.
DOI: 10.3389/fphar.2011.00021.
Acute right heart decompensation in a multiple trauma patient with chronic pulmonary hypertension.
Weber-Carstens S, Lojewski C, Bercker S, Schaser K, Fateh-Moghadam S, Kaisers U
Intensive Care Med. 2011; 37(4):723-4.
PMID: 21234745
DOI: 10.1007/s00134-010-2122-z.
Integrated care and optimal management of pulmonary arterial hypertension.
Strange G, Fowler R, Jary C, Dalton B, Stewart S, Gabbay E
J Multidiscip Healthc. 2011; 2:67-78.
PMID: 21197349
PMC: 3004560.
DOI: 10.2147/jmdh.s3085.
Standard PAH therapy improves long term survival in CTEPH patients.
Seyfarth H, Halank M, Wilkens H, Schafers H, Ewert R, Riedel M
Clin Res Cardiol. 2010; 99(9):553-6.
PMID: 20419456
DOI: 10.1007/s00392-010-0156-4.
Pulmonary arterial hypertension.
Uzunpinar A, Cilingiroglu M
Curr Atheroscler Rep. 2009; 11(2):139-45.
PMID: 19228488
DOI: 10.1007/s11883-009-0022-x.
Interatrial shunt for chronic pulmonary hypertension: differential impact of low-flow vs. high-flow shunting.
Zierer A, Melby S, Voeller R, Moon M
Am J Physiol Heart Circ Physiol. 2009; 296(3):H639-44.
PMID: 19136607
PMC: 2660224.
DOI: 10.1152/ajpheart.00496.2008.
Review of bosentan in the management of pulmonary arterial hypertension.
Gabbay E, Fraser J, McNeil K
Vasc Health Risk Manag. 2008; 3(6):887-900.
PMID: 18200808
PMC: 2350123.